Loading clinical trials...
Loading clinical trials...
This study will estimate the incidence of invasive pneumococcal disease in members of the Northern Kaiser Permanente healthcare system during each of the 5 following introduction of Prevnar 13.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
Collaborators
NCT03384589 · Invasive Pneumococcal Disease, Protection Against, Streptococcus Pneumoniae Infection
NCT04464291 · Pneumonia, Pneumococcal, Invasive Pneumococcal Disease, and more
NCT01694329 · Acute Upper Respiratory Infection, Acute Lower Respiratory Tract Infection, and more
NCT00227188 · Invasive Pneumococcal Disease
NCT00371878 · Pneumonia, Meningitis, and more
Kaiser Permanente Vaccine Study Center
Oakland, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions